Loading...
Biomarker-based adaptive trials for patients with glioblastoma—lessons from I-SPY 2
The traditional clinical trials infrastructure may not be ideally suited to evaluate the numerous therapeutic hypotheses that result from the increasing number of available targeted agents combined with the various methodologies to molecularly subclassify patients with glioblastoma. Additionally, re...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3714161/ https://ncbi.nlm.nih.gov/pubmed/23857706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not088 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|